Who Paid My Doc
Thomas Casale
Allergy & Immunology Tampa, FL Medical Doctor
NPI 1124132535 CMS profile 278171
12901 Bruce B Downs Blvd, Mdc 19, Tampa, FL 33612
General payments
$382,231
Research payments
$109,563
Ownership & investment interest
$0
Research they led as principal investigator
$1,270,676
Through program year 2025, Thomas Casale of Tampa, FL is reported in the CMS Open Payments database as having received $382,231 across 309 general payments and $109,563 in research payments paid to them. Separately, studies naming them as principal investigator received $1,270,676 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $15,785 | 11 | |
| 2025 | Research | $10,083 | 7 | |
| 2024 | General | $70,820 | 65 | |
| 2024 | Research | $20,124 | 11 | |
| 2023 | General | $91,748 | 79 | |
| 2023 | Research | $36,524 | 27 | |
| 2022 | General | $26,555 | 15 | |
| 2022 | Research | $17,896 | 30 | |
| 2021 | General | $27,322 | 20 | |
| 2021 | Research | $10,262 | 9 | |
| 2020 | General | $68,983 | 38 | |
| 2020 | Research | $10,377 | 12 | |
| 2019 | General | $81,018 | 81 | |
| 2019 | Research | $4,298 | 11 |
Beside peers
- Thomas Casale
- Allergy & Immunology median
- Middle half of Allergy & Immunology
- National median
In program year 2025, general payments to Thomas Casale were reported at $15,785. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.
Show as a table
| Year | Thomas Casale | Allergy & Immunology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $81,018 | $594 | $163–$1,512 | $163 |
| 2020 | $68,983 | $426 | $106–$1,233 | $114 |
| 2021 | $27,322 | $638 | $157–$1,708 | $132 |
| 2022 | $26,555 | $790 | $205–$1,961 | $149 |
| 2023 | $91,748 | $852 | $220–$2,147 | $160 |
| 2024 | $70,820 | $865 | $203–$2,267 | $164 |
| 2025 | $15,785 | $1,140 | $272–$2,892 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
416 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Allergy & Immunology in Florida
Related records
Allergy & Immunology in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Allergy & Immunology
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.